BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250320T140000
DTEND;TZID=America/New_York:20250320T150000
DTSTAMP:20260405T130733
CREATED:20250305T194737Z
LAST-MODIFIED:20250306T154410Z
UID:70275-1742479200-1742482800@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A webinar from Takeda on FVIII Portfolio
DESCRIPTION:Date: Thursday\, March 20th\, 2025\nTime: 2:00pm – 3:00pm ET \n \n  \n  \n  \n \nTITLE: \nTakeda FVIII Portfolio \nOBJECTIVE: \nPlease join Takeda leadership to review Takeda FVIII Products & Resources Available. \nINTENDED AUDIENCE: \nAll HTC staff \nSPEAKER: \nAnthea Cherednichenko\, VP US Hematology Franchise Head \nAnthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea previously served as the General Manager for Takeda Austria. Prior to that role\, she was in Global and European leadership roles in Hematology based out of Switzerland. Originally from Australia\, Anthea spent her early career years in medical device and health IT marketing roles in both Australia and Asia\, before joining Baxter (later acquired by Takeda) in 2013. Anthea holds a Master of Public Health from the University of Sidney and Master of Business Administration from Victoria University.
URL:https://hemoalliance.org/alliance-events/a-webinar-from-takeda-on-fviii-portfolio/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR